Current use of statins reduces risk of HIV rebound on suppressive HAART

BACKGROUND: Despite compelling evidence for activity against HIV-1 in vitro, a virologic effect of statins has not been shown in clinical studies. Given their short plasma half-lives, such an effect may be transient and only apparent during ongoing exposure. METHODS: We studied all HIV infected US-V...

Descripción completa

Detalles Bibliográficos
Autores principales: Drechsler, Henning, Ayers, Colby, Cutrell, James, Maalouf, Naim, Tebas, Pablo, Bedimo, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331966/
https://www.ncbi.nlm.nih.gov/pubmed/28249009
http://dx.doi.org/10.1371/journal.pone.0172175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331966/
https://www.ncbi.nlm.nih.gov/pubmed/28249009
http://dx.doi.org/10.1371/journal.pone.0172175

Ejemplares similares